Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AbundRX vs TeleZen MD

AbundRX
Graded #193

Higher grade

vs+6.099999999999994
TeleZen MD
Graded #328

Lower grade

The verdict

AbundRX takes it — 66.3/100 to 60.2/100.

AbundRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AbundRX (Abundant Wellness) is an online medical weight-care platform connecting patients with licensed clinicians for compounded GLP-1 treatment.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAbundRX +22
66
44
Dose & formulationEven
64
64
Clinical oversightTeleZen MD +7
79
86
Labs & monitoringEven
53
53
FulfillmentAbundRX +12
74
62
Contract termsAbundRX +8
55
47
AbundRX · left barTeleZen MD · right bar

The numbers

MetricAbundRXTeleZen MD
WeighScore66.3/10060.2/100
GradeCC
Scorecard rank#193#328
Semaglutide$179/mo (compounded)$198/mo (compounded)
Tirzepatide$279/mo (compounded)$298/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AbundRX

Graded #193 · C

Strengths

  • Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
  • Fast, free shipping and a simple few-minute online health assessment
  • Provider-guided care connecting patients with licensed US clinicians
  • Publishes Terms, Privacy, and Refund policies

Where it loses points

  • Claims LegitScript certification in text but displays no verifiable seal or listing
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Compounding pharmacy not named; no HIPAA notice found; state availability not published
  • Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
TeleZen MD

Graded #328 · C

Strengths

  • Says it serves all 50 states — among the broadest claimed reach in the compounded segment
  • Markets U.S.-based, FDA-registered pharmacies
  • $100 off your first order with code WELCOME100
  • Fully online U.S. telehealth model with physician evaluation
  • Education-forward, physician-led positioning

Where it loses points

  • Partner pharmacy not named
  • Legal entity name and state of incorporation not disclosed
  • Brand-name medications not addressed on the homepage
  • LegitScript certification not confirmed
  • All-50-states claim is the provider's own, not independently verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard